TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZTS

Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

73.00$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ZTS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
37.1% 37.7% 35.7% 35.1% 34.8% 34.3% 33.2% 31.7% 32.2% 31.7% 30.9% 29.5%
62.9% 62.3% 64.3% 64.9% 65.2% 65.7% 66.8% 68.3% 67.8% 68.3% 69.1% 70.5%
8.3% 7.6% 7.7% 7.2% 7.4% 7.3% 6.9% 6.5% 6.7% 7.2% 7.4% 7.4%
28.8% 27.2% 24.5% 22.1% 22.7% 23.5% 22.4% 22.0% 21.3% 21.9% 21.8% 25.1%
42.6% 39.6% 35.6% 32.3% 32.9% 33.5% 32.8% 32.3% 31.5% 32.4% 32.5% 32.5%
20.3% 22.7% 28.7% 32.5% 32.3% 32.2% 34.0% 36.0% 36.2% 35.9% 36.6% 38.0%
2.4% 2.6% 3.4% 3.3% 3.6% 3.9% 3.7% 3.0% 2.9% 3.0% 2.6% 2.6%
17.1% 11.4% 25.1% 28.7% 29.0% 28.8% 29.9% 32.0% 32.9% 34.4% 33.8% 35.5%
4.9% 4.3% 8.4% 12.5% 4.6% 4.8% 5.4% 5.8% 6.7% 7.0% 6.9% 7.3%
12.2% 7.1% 16.8% 16.3% 24.5% 24.0% 24.5% 26.2% 26.2% 27.4% 26.9% 28.2%
23.8% 18.2% 33.4% 36.6% 37.9% 39.2% 40.2% 40.8% 41.6% 43.1% 41.8% 43.0%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?